The Frontier
GPT-6 Astra outscores every specialist at antibody prediction
The rule that AI-for-science requires dedicated models just broke. OpenAI's GPT-6 Astra topped a blind benchmark for predicting whether antibodies can become drugs — beating purpose-built systems without any domain-specific training. GPT-6 Astra scored 37.98 on the DDD Benchmark's antibody